and has a precious
Let us remember
like a walk
through the Forest of our
during a full Moon.
To Treasure our memories
can heal your Spirit and your mind.
Let your body relax
and your mind be calm.
Allow your reflections
to flow with the music
and the magic
of each moment.Wrap
your precious Heart
around the Peace
that prevails in Nature.
The calm you discover
will be conveyed to your
Heart and mind.
And you will be Grateful
is so Beautiful.
The sounds of Mother Nature
are a relaxing melody
in the Dream
that is the Nature of our
It is so very Beautiful.
and very simple,
is frittered away
– Henry David Thoreau
distracted by Nature.
There you will find
and the Freedom
to be Happy.
what your Heart
that creates a Loving memory
will never go away.
will be with you
runs through the Trees
and plays near the echoes
of your mind,
and reminds us
of the Hope in our Hearts.
can run through the Trees
and sit beside the running waters,
making Flower crowns
and enjoying the simple pleasure
of just Being.
the good memories
and be Happy again.
is not about finding yourself.
Life is about creating yourself.
Life is about
being Grateful to the Lord
for every precious Day.
A new chapter
for Humanity is beginning.
The Light and Love
of our Lord
is the only
Embrace His World
and you will open your Heart,
open your mind,
and open the door
to a World
filled with Love.
COVID-19: Advice, updates and vaccine options
Vitamin D is a nutrient your body needs for building and maintaining healthy bones. That’s because your body can only absorb calcium, the primary component of bone, when vitamin D is present. Vitamin D also regulates many other cellular functions in your body. Its anti-inflammatory, antioxidant and neuroprotective properties support immune health, muscle function and brain cell activity.
Vitamin D isn’t naturally found in many foods, but you can get it from fortified milk, fortified cereal, and fatty fish such as salmon, mackerel and sardines. Your body also makes vitamin D when direct sunlight converts a chemical in your skin into an active form of the vitamin (calciferol).
The amount of vitamin D your skin makes depends on many factors, including the time of day, season, latitude and your skin pigmentation. Depending on where you live and your lifestyle, vitamin D production might decrease or be completely absent during the winter months. Sunscreen, while important to prevent skin cancer, also can decrease vitamin D production.
Many older adults don’t get regular exposure to sunlight and have trouble absorbing vitamin D. If your doctor suspects you’re not getting enough vitamin D, a simple blood test can check the levels of this vitamin in your blood.
Taking a multivitamin with vitamin D may help improve bone health. The recommended daily amount of vitamin D is 400 international units (IU) for children up to age 12 months, 600 IU for people ages 1 to 70 years, and 800 IU for people over 70 years.
Research on vitamin D use for specific conditions shows:
- Cancer. Findings on the benefits of vitamin D for cancer prevention are mixed. More studies are needed to determine whether vitamin D supplementation may reduce the risk of certain cancers.
- Cognitive health. Research shows that low levels of vitamin D in the blood are associated with cognitive decline. However, more studies are needed to determine the benefits of vitamin D supplementation for cognitive health.
- Inherited bone disorders. Vitamin D supplements can be used to help treat inherited disorders resulting from an inability to absorb or process vitamin D, such as familial hypophosphatemia.
- Multiple sclerosis. Research suggests that long-term vitamin D supplementation reduces the risk of multiple sclerosis.
- Osteomalacia. Vitamin D supplements are used to treat adults with severe vitamin D deficiency, resulting in loss of bone mineral content, bone pain, muscle weakness and soft bones (osteomalacia).
- Osteoporosis. Studies suggest that people who get enough vitamin D and calcium in their diets can slow bone mineral loss, help prevent osteoporosis and reduce bone fractures. Ask your doctor if you need a calcium and vitamin D supplement to prevent or treat osteoporosis.
- Psoriasis. Applying vitamin D or a topical preparation that contains a vitamin D compound called calcipotriene to the skin can treat plaque-type psoriasis in some people.
- Rickets. This rare condition develops in children with vitamin D deficiency. Supplementing with vitamin D can prevent and treat the problem.
Without vitamin D your bones can become soft, thin and brittle. Insufficient vitamin D is also connected to osteoporosis. If you don’t get enough vitamin D through sunlight or dietary sources, you might need vitamin D supplements.
Safety and side effects
Taken in appropriate doses, vitamin D is generally considered safe.
However, taking too much vitamin D in the form of supplements can be harmful. Children age 9 years and older, adults, and pregnant and breastfeeding women who take more than 4,000 IU a day of vitamin D might experience:
- Nausea and vomiting
- Poor appetite and weight loss
- Confusion and disorientation
- Heart rhythm problems
- Kidney stones and kidney damage
Possible interactions include:
- Aluminum. Taking vitamin D and aluminum-containing phosphate binders, which may be used to treat high serum phosphate levels in people with chronic kidney disease, might cause harmful levels of aluminum in people with kidney failure in the long term.
- Anticonvulsants. The anticonvulsants phenobarbital and phenytoin (Dilantin, Phenytek) increase the breakdown of vitamin D and reduce calcium absorption.
- Atorvastatin (Lipitor). Taking vitamin D might affect the way your body processes this cholesterol drug.
- Calcipotriene (Dovonex, Sorilux). Don’t take vitamin D with this psoriasis drug. The combination might increase the risk of too much calcium in the blood (hypercalcemia).
- Cholestyramine (Prevalite). Taking vitamin D with this cholesterol-lowering drug can reduce your absorption of vitamin D.
- Cytochrome P-450 3A4 (CYP3A4) substrates. Use vitamin D cautiously if you’re taking drugs processed by these enzymes.
- Digoxin (Lanoxin). Avoid taking high doses of vitamin D with this heart medication. High doses of vitamin D can cause hypercalcemia, which increases the risk of fatal heart problems with digoxin.
- Diltiazem (Cardizem, Tiazac, others). Avoid taking high doses of vitamin D with this blood pressure drug. High doses of vitamin D can cause hypercalcemia, which might reduce the drug’s effectiveness.
- Orlistat (Xenical, Alli). Taking this weight-loss drug can reduce your absorption of vitamin D.
- Thiazide diuretics. Taking these blood pressure drugs with vitamin D increases your risk of hypercalcemia.
- Steroids. Taking steroid mediations such as prednisone can reduce calcium absorption and impair your body’s processing of vitamin D.
- Stimulant laxatives. Long-term use of high doses of stimulant laxatives can reduce vitamin D and calcium absorption.
- Verapamil (Verelan, Calan SR). Taking high doses of vitamin D with this blood pressure drug can cause hypercalcemia, and might also reduce the effectiveness of verapamil.
Get the latest health information from Mayo Clinic’s experts.
Sign up for free, and stay up to date on research advancements, health tips and current health topics,
Other Topics in Patient Care & Health Info
A mountain of studies have found an overwhelming amount of people who test positive for Covid-19 do not have enough vitamin D in their bodies and the sickest of patients are often deficient.
Britons are most at risk of being vitamin D deficient between October and April when sunlight levels are too low for the body to make the vitamin – with those with darker skin at even higher risk.
Around two in five Brits are deficient during the winter, when respiratory infections are most common. In the US, at least two in five citizens also lack sufficient levels of the vitamin.
It has led to calls for doctors to dish out cheap vitamin D supplements – which cost as little as 3p a day and have no dangerous side effects – to fight the disease.
It comes as researchers from University of Brighton have today called for care home residents to be given the ‘sunshine vitamin’.
Vitamin D supplements are safe, cheap and readily available – costing as little as 6p a pill and sold in most pharmacies, supermarkets and health shops
As well as in supplements, vitamin D is also available through foods, including oily fish, red meat and eggs. A Singaporean study earlier in the year of nearly 800 people found almost 99% of Covid-19 patients who died had vitamin D deficiency.
CARE HOME RESIDENTS ‘SHOULD BE GIVEN VITAMIN D’
Care home residents are not being given vitamin D, which may be protective against Covid-19, despite Government guidance, researchers say.
Advice from Public Health England from before the pandemic states: ‘People whose skin has little or no exposure to the sun, like those in institutions such as care homes, or who always cover their skin when outside, risk vitamin D deficiency and need to take a supplement throughout the year.’
They should take a daily supplement containing 10 micrograms all year round, and not just in the winter when there is less sunlight.
However, interviews with people involved in elderly residential care, such as GP’s and care home managers in southeast England, found that none was aware of any care home routinely offering the supplement, The Times reported.
Only a dietitian seemed aware of the guidance, according to the findings in the journal BMJ Nutrition, Prevention & Health.
Despite health chiefs advising residents should be given supplements all year round because they rarely go outside, academics found this was not happening in care homes in the south east of England.
Trial volunteers will receive tablets containing either 800 IU or 3,200 IU a day of the vitamin, which they will be asked to take for six months.
There will also be a control group taking the NHS recommended amount of 400IU a day.
Although this level is advised for the winter months, experts said taking more wouldn’t pose a risk as the vitamin is harmless and the body simply removes any excess levels.
Researchers will track the incidence of doctor-diagnosed or laboratory-confirmed acute respiratory infections in participants during the trial, to see whether the supplements have affected their risk or severity of infection.
Dr David Jolliffe, from Queen Mary University of London, said the study had the potential to give a ‘definitive answer’ on whether vitamin D could protect against coronavirus.
‘Vitamin D supplements are low in cost, low in risk and widely accessible; if proven effective, they could significantly aid in our global fight against the virus,’ he said.
Professor Adrian Martineau, who is also involved in the study, said: ‘There is mounting evidence that vitamin D might reduce the risk of respiratory infections, with some recent studies suggesting that people with lower vitamin D levels may be more susceptible to coronavirus.
A study by Tehran University, in Iran, and Boston University analysed data from 235 hospitalised patients with Covid-19. Patients who had sufficient vitamin D – of at least 30 ng/mL— were 51.5 per cent less likely to die from the disease. Although no one in the study under age 40 died, fatalities (red) were more common among vitamin D deficient people (under the black line) of all ages
A correlation graph showing the relationship between levels of viamin D (bottom, measured in nmol/l) compared to infection numbers of coronavirus by the University of East Anglia. Countries with low vitamin D levels tend to have the highest case rates per million – but the graph was from a study in May, when outbreaks looked very different to how they do now and testing was patchy in most countries
University of Chicago researchers studying 500 Americans’ vitamin D levels found 60 per cent higher rates of Covid-19 among people with low levels of the ‘sunshine vitamin’
What have just some of the DOZENS of studies into vitamin D and Covid-19 shown?
Cordoba University in Spain.
What did scientists study? 50 Covid-19 hospital patients with Covid-19 were given vitamin D. Their health outcomes were compared with 26 volunteers in a control group who were not given the tablets.
What did they find? Only one of the 50 patients needed intensive care and none died. Half of 26 virus sufferers who did not take vitamin D were later admitted to intensive care and two died.
What were the study’s limitations? Small pool of volunteers. Patients’ vitamin D levels were not checked before admission. Comorbidities were not taken into consideration.
University of Chicago.
What did scientists study? 500 Americans’ vitamin D levels were tested. Researchers then compared volunteers’ levels with how many caught coronavirus.
What did they find? 60 per cent higher rates of Covid-19 among people with low levels of the ‘sunshine vitamin’.
What were the study’s limitations?
Researchers did not check for other compounding factors. Unclear whether or not volunteers were vitamin D deficient at the time of their coronavirus tests. People’s age, job and where they lived – factors which greatly increase the chance of contracting the virus – were not considered.
Tel Aviv University, Israel.
What did scientists study? 782 people who tested positive for coronavirus had their vitamin d levels prior to infection assessed retrospectively and compared to healthy people.
What did they find? People with vitamin D levels below 30 ng/ml – optimal – were 45 per cent more likely to test positive and 95 per cent more likely to be hospitalized.
What were the study’s limitations? Did not look at underlying health conditions and did not check vitamin D levels at the time of infection.
Brussels Free University.
What did scientists study? Compared vitamin D levels in almost 200 Covid-19 hospital patients with a control group of more than 2,000 healthy people.
What did they find? Men who were hospitalized with the infection were significantly more likely to have a vitamin D deficiency than healthy men of the same age. Deficiency rates were 67 per cent in the COVID-19 patient group, and 49 per cent in the control group. The same was not found for women.
What were the study’s limitations? Independent scientists say blood vitamin D levels go down when people develop serious illness, which the study did not take into consideration. This suggests that it is the illness that is leading to lower blood vitamin D levels in this study, and not the other way around.
Inha University in Incheon, South Korea.
What did scientists study? 50 hospital patients with Covid-19 were checked for levels of all vital vitamins and compared to a control group.
What did they find? 76 per cent of them were deficient in vitamin D, and a severe vitamin D deficiency (<10 ng/dl) was found in 24 per cent of Covid-19 patients and just 7 per cent in the control group.
What were the study’s limitations?
Small sample size and researchers never accounted for vitamin levels dropping when they fall ill.
Independent scientists in Indonesia.
What did scientists study? Checked vitamin D levels in 780 Covid-19 hospital patients.
What did they find? Almost 99% of patients who died had vitamin D deficiency. Of patients with vitamin D levels higher than 30 ng/ml – considered optimal – only per cent died.
What were the study’s limitations? It was not peer-reviewed by fellow scientists, a process that often uncovers flaws in studies.
University of Glasgow.
What did scientists study? Vitamin D levels in 449 people from the UK Biobank who had confirmed Covid-19 infection.
What did they find? Vitamin D deficiency was associated with an increased risk in infection – but not after adjustment for con-founders such as ethnicity. It led to the team to conclude their ‘findings do not support a potential link between vitamin D concentrations and risk of Covid-19 infection.’
What were the study’s limitations? Vitamin D levels were taken 10 to 14 years beforehand.
University of East Anglia.
What did scientists study? Average levels of vitamin D in populations of 20 European countries were compared with Covid-19 infection and death rates at the time.
What did they find? The mean level of vitamin D in each country was ‘strongly associated’ with higher levels of Covid-19 cases and deaths. The authors said at the time: ‘The most vulnerable group of population for Covid-19 is also the one that has the most deficit in vitamin D.’
What were the study’s limitations? The number of cases in each country was affected by the number of tests performed, as well as the different measures taken by each country to prevent the spread of infection. And it only looked at correlation, not causation.
What did scientists study? Crunched data from dozens of studies around the world that included vitamin D levels among Covid-19 patients.
What did they find? Patients with a severe deficiency are twice as likely to experience major complications and die.
What were the study’s limitations? Cases and deaths in each country was affected by the number of tests performed.
‘Vitamin D deficiency is more common in older people, in people who are overweight, and in Black and Asian people – all of the groups who are at increased risk of becoming very ill with Covid-19.
‘The UK government already recommends that people take a low-dose vitamin D supplement over the winter to protect their bone health, but we do not know if this will have an effect on Covid-19 or if higher doses might be able to provide protection against the virus.
‘The CORONAVIT trial will test whether higher doses of vitamin D might offer protection against winter respiratory infections including Covid-19.’
Arguments on the link between Vitamin D deficiency and its observed link with poor Covid-19 outcomes started to gather pace as early as May.
The problem lies in the fact there is a lack of gold-standard medical research – the randomised controlled trials which compare people who are given the supplement with those who are not to see which group fares better.
Only one study has done this so far, conducted by the University of Cordoba in Spain and published last month.
Researchers gave high doses of calcifediol – a type of vitamin D supplement – to 50 patients hospitalised with the disease.
There were no deaths among volunteers receiving the vitamin and all 50 patients were eventually discharged by the end of the study. But two of the 26 patients in a control group, who were not given the tablets, died.
Just one patient given calcifediol felt ill enough to be admitted to intensive care, whereas half of the participants in the control group were taken to ICU and two died.
But many scientists have criticized the study, saying its sample size is too small for any firm conclusions to be drawn about the impact of Vitamin D.
Nonetheless, it was the most promising result for trials of the vitamin so far, and corresponds to earlier research that fixing vitamin deficiency might cut mortality rates by half.
A Northwestern University study, published in May, found Covid-19 patients with a severe Vitamin D deficiency are twice as likely to experience major complications and die.
Nearly 99 per cent of Covid-19 patients who are vitamin D deficient die, according to a study from Indonesian researchers who analysed hospital records of 780 people who tested positive for SARS-CoV-2.
Results revealed 98.9 per cent of infected patients defined as vitamin D deficient — below 20ng/ml — died. Yet this fell to just 4.1 per cent for patients who had enough of the nutrient.
Researchers warned the study was not definitive, however, because the patients with high vitamin D levels were healthier and younger.
Another study by Tehran University, in Iran, and Boston University, found hospital Covid-19 patients who had sufficient vitamin D – of at least 30 ng/mL— were 51.5 per cent less likely to die from the disease.
The study of 235 hospitalized patients with Covid-19 also showed those with enough vitamin D had a significantly lower risk of falling seriously ill or needing ventilation.
Patients who had plenty of the nutrient also had less inflammation – often a deadly side effect of Covid-19.
However, there were flaws in these studies, such as a lack of acknowledgement of confounding factors, such as smoking, and social economic status, which were were not recorded for all patients but could have an impact on illness severity.
Some participants’ underlying health conditions were not defined, despite having a major impact on disease severity.
There have also been at least three studies which have suggested those who have enough vitamin D are less likely to catch the coronavirus in the first place.
But Professor Ian Jones, a virologist at the University of Reading, told MailOnline: ‘My general view is that if there is no clear cut view on vitamin D after six months of debate then there is nothing in it.’
But given the findings so far, it astonished scientists that Mr Hancock was so quick to throw out the ‘sunshine vitamin’ as a potential treatment.
Matt Hancock wrongly told the House of Commons in September that a Government-funded ‘trial’ investigating vitamin D showed it did not ‘appear to have any impact’.
He was told to ‘get his facts straight’ in September after shooting down vitamin D as a potential coronavirus treatment despite a growing body of evidence from around the world suggesting it works.
Liberal Democrat MP Layla Morgan told MailOnline the secretary of state ‘needs to be listening, not dismissing’.
She added: ‘I hope Matt Hancock will take a less flippant approach to potential treatments in future and get his facts straight before making such comments. We’re in a crisis, it’s time for politicians to stop playing science and listen to the experts.’
Chris Chapman, chief executive officer of manufacturer YPV, which offers a home vitamin D test kit, said the company was ‘deeply disappointed’ about Mr Hancock’s comments.
He said: ‘We have seen a mountain of evidence that vitamin D has a positive, and at times life-saving, impact on people suffering with severe symptoms of coronavirus.
‘We fundamentally disagree with the Health Secretary on this matter, his comments display incredible ignorance.
‘We urge him to practice his well-trodden mantra by following the science, which overwhelmingly points to the benefits of vitamin D when it comes tackling coronavirus.’
The ‘sunshine vitamin’ – nicknamed because it is acquired by spending time in the sun – is postulated to protect against Covid-19.
A number of studies have suggested the immune-boosting vitamin could protect people from coronavirus after finding adults deficient in the nutrient are more at risk of catching the disease.
And those who spend more time indoors – such as in a care home – or who have darker skin – those of a Black, Asian or ethnic minority (BAME) background – are also at greater risk of Covid-19.
Officials estimate one in five Britons are deficient in vitamin D — the equivalent of 13million Britons.
But some people are more at risk than others; the rate is up to 90 per cent in people with darker skin who find it harder to obtain the vitamin from the sun.
Advice from PHE states: ‘People whose skin has little or no exposure to the sun, like those in institutions such as care homes, or who always cover their skin when outside, risk vitamin D deficiency and need to take a supplement throughout the year.’
But a recent University of Brighton study suggests care home residents are not being given the supplement.
The article was written by BSMS MSc Public Health graduate Joe Williams and the university’s Principal Lecturer for Health Promotion and Public Health, Carol Williams
The team interviewed four GPs four care home managers, a dietitian, a falls specialist, two public health practitioners and a senior doctor in elderly care, The Times reported.
A report from the Academy of Medical Sciences in July said: ‘It has been suggested that low levels of vitamin D — endemic within the UK, exacerbated by lock down and which worsen over winter — may contribute to susceptibility to Covid-19.’